Organization | Government of Senegal

Government of Senegal Report issue

Government Phase 3

Founded: Dakar Senegal (2001)

Organization Overview

First Clinical Trial

2002

NCT00132561

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Alternative names

Division Controle Medicale Scolaire, Ministry of Education, Senegal | Ministry of Health, Senegal | Programme National de Lutte contre le Paludisme (PNLP), Senegal | Senegal Programme National de Lutte contre le Paludisme (PNLP)

Active Ingredients

Drugs in Phase 3 Trials (6)

amodiaquine (camoquin) (2 trials)

artesunate (2 trials)

azithromycin (zithromax) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

pyrimethamine (daraprim) (3 trials)

sulfadoxine (3 trials)

Drugs in Other Trials (3)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

primaquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 5
# of Trial APIs: 9